vesicular
stomat
viru
vsv
belong
rhabdovirida
encapsid
singlestrand
rna
genom
encod
five
major
protein
vsv
zoonot
viru
epidem
potenti
hors
cattl
swine
caus
signific
econom
burden
livestock
industri
infect
host
cell
vsv
bind
cell
receptor
glycoprotein
g
trigger
endocytosi
follow
uncoat
helic
nucleocapsid
nc
cytoplasm
nucleoprotein
n
encapsid
viral
rna
form
nc
templat
fulllength
nc
replic
transcript
subgenom
mrna
nc
tightli
shield
n
protein
open
transient
rna
synthesi
l
polymeras
phosphoprotein
p
sinc
n
protein
critic
vsv
capsid
viral
replic
ideal
target
host
immun
system
howev
whether
n
protein
target
host
innat
intrins
immun
unknown
fill
knowledg
gap
deepen
understand
host
defens
vsv
also
pave
avenu
develop
therapeut
vsv
infecti
diseas
tripartit
motif
trim
protein
group
ubiquitin
ligas
play
critic
role
innat
immun
signal
well
intrins
immun
ubiquitin
ligas
activ
confer
conserv
ntermin
motif
compris
three
domain
realli
interest
new
gene
ring
b
box
coil
coil
trim
protein
variabl
ctermin
domain
determin
interact
target
protein
trim
protein
well
known
trim
protein
mediat
host
innat
immun
activ
promot
induct
antivir
cytokin
chemokin
type
interferon
ifn
instanc
ubiquitin
cytosol
rna
sensor
retino
acidinduc
gene
rigi
critic
subsequ
rigi
oligomer
activ
interact
human
immunodefici
viru
hiv
capsid
activ
signal
recent
studi
found
trim
protein
also
intrins
immun
factor
limit
viru
infect
directli
target
viral
protein
exampl
ubiquitin
polymeras
basic
influenza
viru
lead
proteasom
degrad
therebi
inhibit
viral
infect
sever
trim
protein
includ
particip
innat
immun
intrins
immun
first
regul
nucleotid
bind
oligomer
domain
contain
cyclic
gmpamp
synthas
cga
innat
immun
signal
pathway
interact
underli
mechan
regul
signal
clear
also
mediat
monoubiquitin
cytosol
dna
sensor
cga
therebi
promot
type
ifn
product
secondli
intrins
immun
factor
inhibit
viral
infect
recent
studi
discov
restrict
influenza
polyubiquitin
degrad
viral
nucleoprotein
moreov
recent
screen
trim
protein
found
seven
trim
protein
inhibit
hepat
b
viru
hbv
transcript
howev
whether
inhibit
virus
vsv
unknown
studi
demonstr
inhibit
vsv
infect
gain
lossoffunct
studi
coimmunoprecipit
found
interact
n
protein
vsv
vsvn
furthermor
ubiquitin
vsvn
cell
vitro
led
proteasom
degrad
vsvn
thu
limit
vsv
replic
overal
studi
establish
new
intrins
immun
host
factor
vsv
cell
atcc
vero
cell
atcc
maintain
dulbecco
modifi
eagl
medium
life
technolog
carlsbad
ca
usa
contain
penicillinstreptomycin
life
technolog
fetal
bovin
serum
life
technolog
cell
atcc
cultur
rpmi
medium
life
technolog
plu
fetal
bovin
serum
mem
nonessenti
amino
acid
solut
life
technolog
vsv
indiana
strain
purchas
atcc
vsv
carri
luciferas
gene
vsvluc
vsv
express
gfp
gene
vsvgfp
kind
gift
dr
sean
whelan
harvard
medic
school
usa
viral
titrat
determin
vero
cell
briefli
vero
cell
infect
serial
dilut
vsv
min
medium
remov
replac
dmem
plu
fb
agaros
h
cell
fix
use
acid
fix
stain
use
coomassi
blue
solut
gener
gift
dr
adolfo
garciasastr
mount
sinai
school
medicin
ny
usa
clone
stratagen
san
diego
ca
usa
gener
delet
mutant
construct
use
sitedirect
mutagenesi
kit
new
england
biolab
ipswich
usa
vsvn
clone
stratagen
gener
flagtag
hatag
vsvn
respect
abcam
cambridg
uk
antiflag
sigma
st
loui
mo
usa
antiubiquitin
santa
cruz
biotechnolog
dalla
tx
usa
aviva
system
biolog
san
diego
ca
usa
antiha
epitop
cell
signal
technolog
danver
usa
antivsv
imani
life
scienc
rochest
mn
usa
antivsvn
kerafast
boston
usa
goat
antimous
igghrp
santa
cruz
biotechnolog
goat
antirabbit
igghrp
santa
cruz
biotechnolog
alexa
fluor
goat
antimous
igg
hl
life
technolog
alexa
fluor
goat
antirabbit
igg
hl
life
technolog
approxim
cell
lyse
tandem
affin
purif
tap
lysi
buffer
mm
trishcl
ph
mm
mm
nacl
nonidet
glycerol
complet
edtafre
proteas
inhibitor
cocktail
tablet
roch
basel
switzerland
min
ice
lysat
centrifug
min
g
supernat
collect
mix
lane
marker
reduc
sampl
buffer
thermo
fisher
scientif
waltham
usa
western
blot
immunoprecipit
perform
describ
previou
studi
cell
cultur
labtek
ii
chamber
slide
system
thermo
fisher
scientif
indic
treatment
cell
fix
permeabil
cold
methanol
min
slide
wash
dpb
min
block
odyssey
block
buffer
licor
bioscienc
lincoln
ne
usa
h
slide
incub
odyssey
block
buffer
dilut
primari
antibodi
h
imag
captur
analyz
use
iristm
digit
cell
imag
system
logo
biosystem
annandal
va
usa
transfect
use
lipofectamin
lipofectamin
transfect
reagent
life
technolog
perform
accord
manufactur
protocol
coip
experi
total
plasmid
transfect
approxim
cell
experi
total
plasmid
transfect
approxim
cell
rnai
target
sequenc
sens
strand
sirna
aaggcgtgctgtggaaataaa
sirna
ttcaataggtgtgaagaggta
sigenom
nontarget
control
sirna
dharmacon
use
control
sirna
five
pmol
sirna
duplex
transfect
cell
use
lipofectamin
rnaimax
transfect
reagent
life
technolog
accord
manufactur
protocol
singl
guid
rna
sgrna
sequenc
target
human
gtagtcttcatcccgcatgg
sgrna
clone
lenticrispr
addgen
cambridg
usa
lentivir
construct
transfect
cell
use
lipofectamin
cell
select
puromycin
day
singl
clone
expand
knockout
confirm
western
blot
dna
sequenc
vitro
ubiquitin
assay
perform
accord
manufactur
manual
boston
biochem
cambridg
usa
ubiquitin
boston
biochem
vsvnflag
delringha
bound
antiha
resin
sigma
incub
ubiquitin
assay
reaction
buffer
boston
biochem
h
antiha
resin
wash
urea
min
exclud
potenti
bind
unanchor
polyubiquitin
resin
incub
mgml
ha
peptid
elut
vsvn
protein
eluat
subsequ
analyz
sdspage
follow
western
blot
sampl
size
suffici
data
analysi
use
pair
twotail
student
ttest
statist
analys
differ
consid
statist
signific
valu
p
examin
effect
vsv
infect
first
transfect
flagtag
cell
h
cell
infect
vsv
report
viru
carri
luciferas
gene
viral
genom
vsvluc
shown
figur
ectop
express
inhibit
vsv
replic
activ
corrobor
find
perform
assay
determin
effect
overexpress
product
infecti
vsv
particl
overexpress
reduc
vsv
viral
titer
significantli
time
cours
h
h
figur
taken
togeth
data
suggest
antivsv
host
factor
corrobor
gainoffunct
examin
effect
deplet
vsv
infect
first
deplet
use
small
interf
rna
sirna
two
valid
sirna
duplex
individu
transfect
lung
epitheli
cell
h
cell
infect
vsvluc
h
knockdown
increas
vsv
infect
activ
cell
figur
secondli
wild
type
knockout
cell
use
previou
studi
infect
differ
dose
vsvluc
h
report
assay
demonstr
increas
viral
infect
knockout
cell
figur
lastli
viral
titer
determin
assay
wild
type
vs
knockout
cell
vsv
viral
titer
increas
knockout
cell
compar
wild
type
cell
figur
suggest
deplet
impair
host
defens
vsv
infect
previous
report
interact
influenza
viral
protein
limit
viral
infect
therefor
plausibl
also
interact
vsv
protein
inhibit
viral
infect
regard
flagtag
g
p
n
vsv
cotransfect
hatag
cell
coimmunoprecipit
coip
reveal
specif
interact
n
protein
vsv
vsvn
figur
b
next
examin
subcellular
local
vsvn
immunofluoresc
assay
flagtag
vsvn
hatag
transfect
alon
togeth
cell
immunofluoresc
assay
show
express
cytoplasm
nucleu
vsvn
exclus
express
cytoplasm
figur
coloc
vsvn
cytoplasm
figur
examin
coloc
endogen
vsvn
viral
infect
cell
cultur
chamber
slide
infect
moi
vsv
h
consist
ectop
express
endogen
express
cytoplasm
nucleu
figur
vsvn
express
cytoplasm
coloc
cytoplasm
figur
data
suggest
interact
coloc
vsvn
trim
protein
ubiquitin
ligas
thu
examin
whether
enzymat
activ
requir
antivsv
function
sinc
ring
domain
confer
ubiquitin
ligas
activ
trim
protein
first
examin
effect
ring
delet
mutant
delr
aa
delet
vsv
infect
delr
transfect
cell
follow
infect
differ
moi
vsvluc
h
luciferas
report
assay
show
delr
fail
inhibit
vsv
infect
figur
reconstitut
fulllength
delr
knockout
cell
transfect
h
cell
infect
vsv
carri
gfp
vsvgfp
shown
figur
fulllength
delr
restor
antivir
activ
vsv
knockout
cell
lastli
examin
viral
titer
knockout
cell
reconstitut
fulllength
vs
delr
line
report
assay
delr
fail
suppress
vsv
infect
evidenc
assay
figur
taken
togeth
ubiquitin
ligas
activ
indispens
antivir
function
requir
ubiquitin
ligas
activ
suggest
might
inhibit
vsv
infect
ubiquitin
vsvn
examin
whether
conjug
ubiquitin
molecul
onto
vsvn
first
perform
vitro
ubiquitin
assay
shown
figur
delr
conjug
ubiquitin
molecul
onto
vsvn
consist
overexpress
wild
type
delr
mutant
induc
ubiquitin
vsvn
cell
figur
next
examin
vsvn
ubiquitin
knockout
cell
vsvn
transfect
hatag
ubiquitin
wild
type
knockout
cell
knockout
dramat
reduc
level
polyubiquitin
chain
conjug
onto
vsvn
figur
experi
suggest
mediat
polyubiquitin
vsvn
polyubiquitin
often
lead
proteasom
degrad
target
protein
thu
examin
whether
mediat
vsvn
protein
degrad
vsvn
cotransfect
delr
cell
overexpress
fulllength
reduc
vsvn
express
howev
delr
margin
effect
express
vsvn
protein
figur
furthermor
treat
cell
proteas
inhibitor
determin
whether
protein
degrad
vsvn
proteasomedepend
cell
transfect
vsvn
along
vector
h
cell
treat
proteasom
inhibitor
h
western
blot
analysi
found
treatment
block
vsvn
degrad
figur
combin
data
indic
mediat
ubiquitin
vsvn
lead
vsvn
proteasom
degrad
therebi
inhibit
vsv
infect
determin
whether
target
vsvn
incom
vsv
cell
first
infect
wild
type
knockout
cell
vsvgfp
h
wash
away
vsv
medium
ad
antivsv
antibodi
neutral
newli
releas
vsv
virion
therefor
cell
singl
cycl
infect
shown
figur
knockout
cell
suscept
singl
cycl
infect
wild
type
cell
suggest
limit
vsv
infect
target
vsvn
incom
viru
innat
immun
intrins
immun
frontlin
host
defens
invad
virus
innat
immun
compris
variou
signal
cascad
lead
express
type
ifn
mani
antivir
gene
innat
immun
signal
pathway
trigger
product
byproduct
microb
usual
foreign
host
tolllik
receptor
rigi
sensor
recogn
ppprna
vsv
endosom
cytoplasm
respect
upon
engag
viral
rna
rigi
activ
signal
cascad
lead
induct
type
ifn
express
unlik
innat
immun
factor
intrins
immun
factor
group
constitut
express
host
factor
preexist
express
host
factor
guarante
rapid
respons
direct
inhibit
viral
infect
exampl
cytidin
deaminas
apolipoprotein
edit
complex
g
introduc
transvers
mutat
hiv
genom
therebi
imped
hiv
infect
well
establish
innat
immun
respond
vsv
infect
howev
intrins
immun
respons
vsv
still
elus
report
interact
n
protein
vsv
subsequ
target
ubiquitin
proteasom
degrad
previou
studi
show
constitut
express
thu
new
intrins
immun
factor
vsv
belong
trim
famili
consist
member
recent
mani
trim
protein
identifi
intrins
immun
factor
curb
viral
infect
directli
target
viral
protein
instanc
restrict
influenza
viru
target
protein
ubiquitin
degrad
restrict
hepat
c
viru
target
ubiquitin
degrad
interact
nonstructur
protein
japanes
enceph
viru
mediat
ubiquitin
protein
degrad
studi
show
inhibit
vsv
infect
mediat
proteasom
degrad
n
protein
note
anoth
trim
protein
pml
also
known
impli
role
vsv
infect
overexpress
pml
cho
cell
increas
resist
infect
vsv
furthermor
pml
defici
increas
mice
suscept
vsv
infect
recent
mechanist
studi
show
pml
enhanc
ifn
synthesi
regul
cellular
distribut
peptidylprolyl
cistran
isomeras
interact
pml
endogen
prevent
degrad
activ
therebi
potenti
product
ifn
previou
studi
demonstr
directli
restrict
influenza
viru
ubiquitin
degrad
nucleoprotein
also
inhibit
hbv
activ
depend
ubiquitin
ligas
activ
ctermin
domain
thu
emerg
broadspectrum
antivir
factor
like
sever
trim
protein
report
broadspectrum
antivir
activ
pml
also
inhibit
herp
viru
adenoassoci
viru
restrict
influenza
b
viru
hiv
yellow
fever
viru
dengu
viru
reduc
viral
rna
level
ctermin
tail
restrict
encephalomyocard
viru
influenza
viru
hepat
b
viru
hepat
c
viru
howev
underli
mechan
broadspectrum
antivir
activ
trim
protein
unknown
determin
broadspectrum
antivir
activ
import
identifi
common
mechan
futur
studi
determin
whether
interact
viral
protein
share
common
motif
interact
conclus
demonstr
target
n
protein
inhibit
vsv
infect
n
protein
cover
entir
vsv
genom
rna
play
import
role
viral
transcript
replic
make
n
protein
ideal
drug
target
thu
studi
provid
foundat
futur
develop
antivir
therapeut
